What: The only event where the industry leaders driving the business of biosimilars come together to set the standards shaping the rapidly evolving legal and regulatory landscape. Whether you are on the branded or generic side, you cannot afford to miss this opportunity because you will: Hear directly from the FDA on how they will […]